Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    PROs in regulatory decision making

    PROs in regulatory decision making

    FromThe Lancet Oncology in conversation with

    Start listeningView podcast show

    PROs in regulatory decision making

    FromThe Lancet Oncology in conversation with

    ratings:
    Length:
    12 minutes
    Released:
    Apr 25, 2018
    Format:
    Podcast episode

    Description

    Paul Kluetz from the US FDA discusses the issues surrounding the use of patient-reported outcomes in regulatory decision making.Continue this conversation on social!Follow us today at...https://twitter.com/thelancet & https://Twitter.com/TheLancetOncolhttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
    Released:
    Apr 25, 2018
    Format:
    Podcast episode

    Titles in the series (100)

    Editors of The Lancet Oncology and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.